Oxford Nanopore, the UK-based DNA sequencing technology spinout of University of Oxford, went public yesterday after issuing 82.4 million shares priced at £4.25 ($5.81) each for $478m in proceeds.

The initial public offering valued Oxford Nanopore at $4.7bn and existing shareholders, including commercialisation firm IP Group, offloaded $238m worth of stock.

Software producer Oracle had already committed to being a cornerstone investor for the IPO, putting aside $205m last week.

Shares soared 45% on the first day of trading…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?
Thierry Heles

Thierry Heles is the editor of Global University Venturing, host of the Beyond the Breakthrough interview podcast and responsible for the monthly GUV Gazette (sign up here for free).
email
Linked in